The Institute Of Molecular And Translational Medicine, Czech Republic
Clinical trials sponsored by The Institute Of Molecular And Translational Medicine, Czech Republic, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Mail-in HPV test could save lives of women skipping pap smears Results expected Dec 2026 (estimated)
- Breath prints may reveal lung disease secrets without needles Results expected Dec 2026 (estimated)
- Cervical mucus may hold key to better IVF timing Results expected Dec 2026 (estimated)
-
Could an alcoholism drug plus copper fight breast cancer?
Disease control CompletedThis Phase 2 trial tested whether disulfiram (Antabuse), a drug used for alcoholism, combined with copper supplements could help people with metastatic breast cancer who had run out of standard options. Only 9 patients took part, and researchers measured tumor response and surviv…
Phase 2 • Sponsor: The Institute of Molecular and Translational Medicine, Czech Republic • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Olomouc study reveals how many have COVID antibodies
Knowledge-focused CompletedThis study looked at nearly 2,500 adults in the Olomouc region to find out how many had antibodies or cellular immunity against the SARS-CoV-2 virus, either from a past infection or from vaccination. Participants gave blood samples and answered a questionnaire. The goal was to un…
Sponsor: The Institute of Molecular and Translational Medicine, Czech Republic • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC